The decision comes after a study showed it offered reduced protection from the Covid-19 variant first identified in that country

South African health officials said Sunday they’re pausing the country’s rollout of AstraZeneca’s coronavirus vaccine after a study showed it offered reduced protection from the Covid-19 variant first identified in that country.